In a move that blurs the boundaries between industries, Faraday Future — the California electric vehicle company — has committed roughly $41 million to acquire majority control of Qualigen Therapeutics, a cancer drug developer it intends to transform into a crypto and Web3 platform. The deal, anchored by founder YT Jia's personal investment and backed by names like Binance Labs, Sequoia Capital, and Circle, reflects a broader human restlessness with singular identity — the impulse to become something more, or something else, before the present chapter is fully written. Whether this dual ambiti
The Manila Times
· Sep 19, 2025
· technology
· 5 min de lectura
High
Verificación: Caracterizado
Faraday Future invests $41M in Qualigen Therapeutics to launch crypto and Web3 business
◉
Economy & Finance
6330 artículos relacionados
Chinese robotics giant Unitree soars 600% in Shanghai debut
BBC News · 100% coincidencia
Dollar Weakens as Treasury Yields Ease; Fed Minutes in Focus
CNBC · 99% coincidencia
Stock futures flat as Wall Street opens week lower amid oil surge and …
Google News · 99% coincidencia
30-Year Treasury Yields Hit 19-Year High Amid Bond Selloff
Google News · 99% coincidencia
Gold extends rally as rate-hike fears ease, Fed minutes eyed
CNBC · 99% coincidencia
Cobertura Relacionada
The New York Times · Aug 20
Bond Market Turmoil Signals Broader, Lasting Inflation Ahead
A significant bond market sell-off is driving up interest rates with potentially lasting effects on affordability across…
The New York Times · Aug 20 Pixelated Chinese Film Becomes Gen Z Hit by Rejecting AI Perfection"The Bull is Coming," a pixelated low-budget Chinese film, is resonating with Gen Z audiences who value its authentic ae…
CNBC · Aug 20 Walmart Q2 earnings offer window into K-shaped consumer divideWalmart reports Q2 earnings Thursday with analyst expectations of 74 cents EPS and $186.77B revenue, offering insight in…
Lipper Alpha Insight · Aug 20 Asian Fund Assets Surge to $10.21T in Q2 2026, Driven by China and Taiwan GrowthAsian-domiciled funds reached $10.21 trillion in Q2 2026, up 16.4% quarterly and 20.3% annually, driven by China, Japan,…
Sesgo y Encuadre
⚖
Article presents a corporate investment announcement with promotional language favoring Faraday Future's strategic positioning and crypto venture, lacking critical analysis of risks or skeptical perspective.
Bias Direction
center-right
Confidence
HIGH
Press release repackaging with promotional framing that emphasizes deal prestige through name-dropping elite investors (Sequoia, Binance Labs) and leadership appointments, while presenting the transaction as strategically significant without critical scrutiny.
global shared intelligent electric mobility ecosystem company
cornerstone investor
peak token valuation of $1.35 billion
building software infrastructure for governments and the next generation of capital markets
strategic investment
Independent financial analyst assessment of deal valuation fairness
Qualigen Therapeutics shareholders' concerns or dissenting views
Regulatory scrutiny of crypto/Web3 business expansion by EV company
Risk analysis regarding Faraday Future's financial stability and track record
Skeptical perspective on the legitimacy or viability of the crypto venture
Impact on Qualigen's original therapeutic business focus
Impacto Geopolítico
🌎
US EV company Faraday Future's $41M investment in biotech firm Qualigen to launch crypto/Web3 business signals convergence of traditional industries with blockchain, backed by Binance Labs and major VCs.
Escalation Risk
low
Confidence
MED
United States
China
India
Global cryptocurrency markets
Reflects growing influence of Chinese-founded companies (Faraday Future, YT Jia) in US capital markets and crypto infrastructure. Binance Labs' involvement extends Chinese blockchain ecosystem influence into US public markets. Sequoia Capital's multi-regional participation shows institutional acceptance of crypto convergence.
Similar to early 2000s tech convergence when traditional industries absorbed internet startups; represents normalization of crypto/Web3 in mainstream corporate finance despite regulatory uncertainty.
Lente Económico
📈
Faraday Future invests $41M in Qualigen Therapeutics to pivot into crypto/Web3, gaining majority control and strategic influence over a therapeutics company, signaling sector diversification but raising governance and regulatory concerns.
Market Signal
mixed
Confidence
MED
Electric vehicles/Automotive
Biotechnology/Pharmaceuticals
Cryptocurrency/Digital Assets
Web3/Blockchain Technology
Capital Markets Infrastructure
Unclear near-term consumer benefits; potential risks if therapeutics development is deprioritized for crypto ventures. Consumers may face delayed pharmaceutical innovations while company pursues speculative digital asset business.
Likely regulatory scrutiny from SEC regarding PIPE structure, crypto business licensing, and governance conflicts. FDA may question Qualigen's commitment to drug development pipeline. Potential policy responses on corporate pivots into unrelated high-risk sectors and crypto venture oversight.